Industry Verticals »

All Categories

Insights »

About TMR »

Genomic Surveillance/Sequencing Market

Genomic Surveillance/Sequencing Market (By Product & Service: Instruments/Systems, Consumables & Reagents, Software & Data Analytics, Services; By Technology: NGS, Sanger Sequencing, PCR-based Sequencing/Detection, Microarray Technology, Nanopore Sequencing, Others; By Workflow; By Application: Infectious Disease Surveillance, Oncology, Genetic & Rare Disease Testing, Reproductive Health, Agricultural & Environmental Genomics, Forensic Genomics; and by End-user) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2026-2036

Genomic Surveillance/Sequencing Market Outlook 2036

The market was valued at USD 13.8 Billion in 2025 and is projected to reach USD 74.1 Billion by 2036, expanding at a CAGR of 16.5% from 2026 to 2036. The market is expected to expand as sequencing costs decline and demand for precision diagnostics increases across oncology, infectious diseases, reproductive health, and rare disease testing. Sequencing is increasingly adopted across hospitals, research laboratories, and biotechnology companies, extending beyond specialized research applications. Advances in nanopore and long-read sequencing technologies are enabling new applications, including real-time pathogen surveillance and rare disease diagnosis.

Market Size & Highlights

  • The genomic surveillance/sequencing market reached USD 13.8 Billion in 2025.
  • The market is estimated to reach USD 74.1 Billion by 2036.
  • The genomic surveillance/sequencing industry is anticipated to expand at a CAGR of 16.5% from 2026 to 2036.
  • Top companies include Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche, Pacific Biosciences, Oxford Nanopore Technologies, etc.
  • North America dominated the market in 2025, holding the largest revenue share of 46.3%.
  • By product & service, the consumables & reagents segment held the largest market share of 48.9% in 2025.

Genomic Surveillancesequencing Market By Revenue

Analysts’ Viewpoint on the Genomic Surveillance/Sequencing Market

The global genomic surveillance/sequencing market is transitioning from specialized research use toward broader clinical, diagnostic, and public health applications. The substantial decline in sequencing costs over the past decade has been a major factor supporting adoption beyond large academic and research institutions, enabling hospitals, diagnostic laboratories, biotechnology companies, and public health agencies to incorporate sequencing into a wider range of workflows.

Oncology remains one of the most important application areas, supported by increasing use of tumor profiling, companion diagnostics, and liquid biopsy. Reproductive health applications, including non-invasive prenatal testing and carrier screening, are also witnessing steady adoption, particularly across developed healthcare markets. Infectious disease surveillance represents another strategically important application as governments and public health agencies continue investing in outbreak preparedness and pathogen-monitoring capabilities. Advances in nanopore and long-read sequencing technologies are expanding the range of addressable applications, including structural-variant analysis, rare disease diagnosis, complex genome assembly, and real-time pathogen surveillance. Sequencing costs are expected to continue declining as platform efficiency, reagent utilization, throughput, and automation improve.

From a competitive perspective, the market remains concentrated around established sequencing-platform providers with substantial installed bases and recurring consumables revenues. However, established companies face increasing competition from emerging providers of long-read, benchtop, and alternative sequencing platforms. Competitive differentiation is increasingly influenced by sequencing accuracy, throughput, workflow simplicity, cost per sample, data-analysis capabilities, and clinical integration. The long-term outlook remains favorable, although competitive and operational risks persist. Companies that improve workflow efficiency, expand data-analytics capabilities, and strengthen integration across sequencing, interpretation, and clinical decision-making are expected to be better positioned to capture emerging opportunities.

Market Introduction

Genomic sequencing involves determining the nucleotide sequence of an organism's genome to characterize its genetic composition. A process that once required years of work and substantial investment has evolved into a faster and increasingly cost-efficient technology used across hospitals, diagnostic laboratories, pharmaceutical companies, biotechnology firms, research institutions, and public health agencies. The genomic surveillance/sequencing market includes sequencing instruments and systems, reagents and consumables, software and data-analytics platforms, and sequencing-related services. These products and services support workflows ranging from sample and library preparation to sequencing, data processing, interpretation, and downstream analysis.

Applications have expanded considerably beyond basic research. Sequencing technologies are now used in oncology, rare disease diagnosis, reproductive health, infectious disease surveillance, agricultural and environmental genomics, forensic genomics, and other clinical and research applications. Market expansion is supported by declining sequencing costs, increasing clinical adoption, improvements in sequencing speed and accuracy, and growing integration of genomic information into healthcare decision-making. As sequencing technologies continue to improve and become more accessible, adoption is expected to broaden across both developed and emerging healthcare systems.

Attribute Detail
Genomic Surveillance/Sequencing Market Drivers
  • Declining Sequencing Costs
  • Growing Cancer and Genetic Disease Burden

Declining Sequencing Costs Support Broader Adoption of Genomic Testing

The sustained reduction in per-genome sequencing costs is one of the major drivers of the global genomic surveillance/sequencing market. Declining costs are improving the economic feasibility of large-scale sequencing and enabling adoption beyond major research institutions into hospitals, diagnostic laboratories, biotechnology companies, and public health organizations.

According to data tracked by the National Human Genome Research Institute, sequencing costs have declined substantially since the early stages of human genome sequencing. A major inflection point occurred following the introduction and broader commercialization of next-generation sequencing technologies, which significantly increased throughput while reducing the cost of generating genomic data. Recent sequencing-platform developments continue to focus on lowering cost per genome and increasing throughput. High-throughput systems from sequencing technology providers are enabling laboratories to process larger numbers of samples while reducing per-sample costs. Competitive developments across sequencing platforms are also encouraging further improvements in reagent efficiency, workflow automation, and instrument utilization.

Regional differences in sequencing costs continue to influence adoption rates. Infrastructure availability, laboratory capacity, reagent procurement, equipment utilization, and workforce capabilities vary considerably across markets, meaning that improvements in affordability are not uniform globally. Nevertheless, continued declines in sequencing costs are lowering one of the major barriers to adoption. As testing volumes increase and sequencing moves further into routine clinical, diagnostic, and public health workflows, cost reductions are expected to remain an important structural driver of market growth.

Growing Cancer and Genetic Disease Burden Strengthens Demand for Genomic Testing

The growing prevalence of cancer and genetic disorders is a key driver of the global genomic surveillance/sequencing market, as healthcare systems increasingly use genomic technologies for early detection, diagnosis, treatment selection, disease monitoring, and personalized medicine. Cancer represents an important application area for sequencing technologies. Genomic profiling supports identification of clinically relevant mutations, selection of targeted therapies, development of companion diagnostics, and monitoring through applications such as liquid biopsy. As the global cancer burden increases, demand for sequencing-based oncology testing is expected to expand.

Genetic and congenital disorders represent another important area of demand. Genomic sequencing can support diagnosis of inherited conditions, rare diseases, chromosomal abnormalities, and other genetic disorders that may be difficult to identify using conventional diagnostic methods. Prenatal and reproductive health applications are also contributing to market growth. Non-invasive prenatal testing, carrier screening, and diagnostic sequencing are increasingly being integrated into reproductive healthcare pathways, particularly as awareness and accessibility improve. Increasing cancer incidence and the persistent burden of genetic and congenital disorders are expanding the population requiring genomic diagnosis and monitoring. As healthcare systems place greater emphasis on early detection, precision medicine, and individualized treatment strategies, these disease trends are expected to remain a structural driver of sequencing demand during the forecast period.

Attribute Detail
Genomic Surveillance/Sequencing Market Opportunities
  • Emerging Economies Create Significant Growth Opportunities

Emerging Economies Create Significant Growth Opportunities for Genomic Sequencing

Emerging economies represent a significant growth opportunity for the genomic sequencing market as governments, research institutions, and healthcare organizations expand national genomics capabilities and invest in sequencing infrastructure. India illustrates this trend through large-scale population genomics initiatives designed to improve representation of genetically diverse populations in genomic databases. The Genome India Project has generated whole-genome sequencing data across thousands of individuals, creating a foundation for future applications in diagnostics, pharmacogenomics, population health, and precision medicine.

The broader biotechnology ecosystem is also expanding rapidly. Growth in biotechnology investment, startup formation, research infrastructure, and government-supported life sciences initiatives is creating a larger base of potential sequencing customers across research, diagnostics, pharmaceutical development, and public health. India also ranks among the leading biotechnology markets globally and within Asia Pacific, reflecting an increasingly supportive environment for genomics investment and infrastructure development. Similar public genomics initiatives are emerging across other developing economies as governments seek population-specific genetic data to support disease prevention, healthcare planning, and drug development.

For sequencing-platform manufacturers, reagent suppliers, bioinformatics companies, and service providers, these markets offer significant early-mover opportunities. Large and genetically diverse populations, increasing public investment, and relatively low sequencing penetration compared with developed markets create considerable potential for future expansion. Companies that establish local partnerships, distribution networks, technical-support capabilities, and regulatory expertise may be better positioned to participate in future market growth as emerging markets transition from pilot-scale genomics programs toward sustainable clinical and research applications.

Consumables & Reagents Holds the Largest Share in the Product & Service Segment

Genomic Surveillancesequencing Market By Type

The consumables and reagents segment dominated the global genomic surveillance/sequencing market in 2025, accounting for approximately 48.9% of total market revenue. The segment's leading position is supported by the recurring use of reagents, flow cells, library preparation kits, sequencing chemicals, and other consumable products across sequencing workflows. Unlike sequencing instruments, which typically represent periodic capital investments, consumables are required for each sequencing run. This creates a recurring revenue model linked directly to sequencing volumes and laboratory utilization.

The National Human Genome Research Institute treats reagents and other consumable inputs as important components of sequencing production costs when evaluating the economics of genome sequencing. As laboratories increase sample throughput, expenditure on consumables rises proportionally with sequencing activity. This consumption-based model becomes increasingly important as sequencing volumes increase. Declining cost per genome is encouraging sequencing to move from relatively limited research applications toward routine clinical testing, population genomics, public health surveillance, and large-scale research programs.

National genomics initiatives involving thousands of samples further demonstrate the recurring requirement for library preparation materials, flow cells, reagents, and other sequencing inputs. As clinical and research sequencing volumes continue to expand, these dynamics are expected to support sustained demand for consumables and reagents, even as sequencing instruments become more efficient.

Regional Outlook of Genomic Surveillance/Sequencing Market

Genomic Surveillancesequencing Market By Region

Attribute Detail
Leading Region
  • North America

North America dominated the global genomic surveillance/sequencing market in 2025, accounting for approximately 46.3% of total market revenue. The region's leading position is supported by its strong research infrastructure, substantial healthcare expenditure, extensive sequencing capacity, and continued government and private-sector investment in genomics. The U.S. represents the largest market within North America due to the presence of leading sequencing companies, pharmaceutical and biotechnology firms, academic medical centers, diagnostic laboratories, genomic research institutes, and public health organizations.

Federal investment through institutions such as the National Institutes of Health, National Human Genome Research Institute, and National Cancer Institute supports a strong ecosystem of research programs, sequencing centers, clinical studies, and technology-development initiatives. This funding environment contributes to continued development and adoption of advanced sequencing technologies. North America also benefits from an extensive network of research institutions and a mature biotechnology and pharmaceutical sector. These capabilities support adoption of sequencing across oncology, rare disease diagnostics, reproductive health, infectious disease surveillance, drug development, and population genomics. Ongoing investment in sequencing technology, bioinformatics, data analysis, and clinical integration is expected to strengthen the region's position during the forecast period. The combination of research funding, established laboratory infrastructure, and commercial innovation provides North America with a structural advantage in sequencing capacity, clinical adoption, and downstream commercialization.

Analysis of Key Players in Genomic Surveillance/Sequencing Market

The competitive landscape of the global genomic surveillance/sequencing market includes established sequencing-platform manufacturers, long-read technology providers, consumables and reagents companies, bioinformatics providers, diagnostics companies, and sequencing-service organizations. Illumina, Inc. has established a substantial installed base of short-read sequencing platforms, supported by a broad portfolio of consumables, reagents, software, and clinical partnerships. Its recurring consumables model and extensive platform adoption provide a strong position across research and clinical sequencing applications. Thermo Fisher Scientific Inc. maintains a broad scale of operations and integrated life sciences capabilities spanning sequencing instruments, sample preparation, reagents, laboratory workflows, and downstream analysis. F. Hoffmann-La Roche Ltd. combines sequencing technology with established capabilities in diagnostics and pharmaceuticals, supporting integration of genomic information into oncology testing, companion diagnostics, and precision medicine applications.

Pacific Biosciences of California, Inc. and Oxford Nanopore Technologies plc are prominent providers of long-read sequencing technologies. These platforms are increasingly important for structural-variant detection, complex genome assembly, rare disease research, and real-time sequencing applications. QIAGEN N.V. and Agilent Technologies, Inc. maintain strong positions in sample preparation, library preparation, reagents, and downstream genomic analysis. Their products support multiple stages of sequencing workflows beyond the instrument itself.

BGI Genomics Co., Ltd. maintains significant high-throughput sequencing capabilities and a strong presence across Asia Pacific, supported by large-scale genomics infrastructure and sequencing-service capabilities. Competition increasingly reflects the distinct strengths of companies across the value chain. Sequencing-platform providers compete on instrument performance, throughput, accuracy, and installed base; consumables providers benefit from recurring sequencing volumes; and diagnostics and bioinformatics companies differentiate through clinical interpretation, workflow integration, and data-analysis capabilities.

Key Developments in Genomic Surveillance/Sequencing Market

  • In June 2026, F. Hoffmann-La Roche Ltd. launched AXELIOS 1, a next-generation sequencing platform based on its proprietary sequencing by expansion (SBX) technology. The platform is designed to support same-day, end-to-end whole-genome sequencing with high accuracy, speed, and scalability for research laboratories. Roche also announced collaborations with Hartwig Medical Foundation, Broad Clinical Labs, and 10x Genomics to support early applications of the platform.
  • In February 2026, Illumina, Inc. launched TruPath Genome, a new whole-genome sequencing solution positioned as a new standard in genomic insight, offering a simplified workflow that eliminates traditional library preparation, generating up to 16 whole genomes per day at a list price of USD 395 per sample, with improved accuracy and resolution across complex genomic regions relevant to genetic disease research.
  • In October 2025, PacBio announced major upgrades to its Revio and Vega sequencing systems, introducing new SPRQ-Nx sequencing chemistry designed to deliver its most affordable HiFi genome to date, with customers operating at scale expected to see up to a 40% reduction in cost, bringing per-genome pricing below USD 300 once the chemistry becomes fully commercially available in 2026.
  • In January 2025, QIAGEN N.V. announced a partnership with Genomics England to support the Generation Study, a national initiative to sequence the genomes of 100,000 newborns in England for over 200 actionable genetic conditions, with QIAGEN serving as the sole provider of clinically curated variant content through its Clinical Knowledge Base to support rapid interpretation and reporting of sequencing results.

Genomic Surveillance/Sequencing Market Snapshot

Attribute Detail
Size in 2025 USD 13.8 Billion
Forecast Value in 2036 USD 74.1 Billion
CAGR 16.5%
Forecast Period 2026-2036
Historical Data Available for 2021-2025
Quantitative Units USD Billion
Genomic Surveillance/Sequencing Market Analysis It includes segment analysis and regional level analysis. Qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis and key trend analysis.
Competition Landscape
  • Competition Matrix
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation Product & Service
  • Instruments/Systems
  • Consumables & Reagents
  • Software & Data Analytics
  • Services
Technology
  • Next-Generation Sequencing (NGS)
  • Sanger Sequencing
  • PCR-based Sequencing/Detection
  • Microarray Technology
  • Nanopore Sequencing
  • Others
Workflow
  • Pre-Sequencing (Sample Prep, Library Prep)
  • Sequencing
  • Data Analysis
Application
  • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
  • Oncology
  • Genetic & Rare Disease Testing
  • Reproductive Health (NIPT, Carrier Screening)
  • Agricultural & Environmental Genomics
  • Forensic Genomics
End-user
  • Hospitals & Diagnostic Laboratories
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Government & Public Health Agencies
  • Contract Research Organizations (CROs)
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • The Netherlands
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Brazil
  • Mexico
  • Argentina
  • GCC Countries
  • South Africa
Companies Profiled
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies plc
  • BGI Genomics Co., Ltd.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Revvity, Inc.
  • Danaher Corporation
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific SE
  • Twist Bioscience Corporation
  • Guardant Health, Inc.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • 10x Genomics, Inc.
  • Element Biosciences, Inc.
  • Singular Genomics Systems, Inc.
  • Other Prominent Players
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global genomic surveillance/sequencing market in 2025?

The market was valued at USD 13.8 Billion in 2025.

How big will the global genomic surveillance/sequencing industry be in 2036?

The industry is projected to reach USD 74.1 Billion by 2036.

What are the factors driving the genomic surveillance/sequencing market?

Declining sequencing costs and the growing burden of cancer and genetic diseases, which are supporting broader adoption of genomic testing.

What will be the CAGR of the global genomic surveillance/sequencing market during the forecast period?

The market is anticipated to expand at a CAGR of 16.5% from 2026 to 2036.

Which region will account for the largest share of the genomic surveillance/sequencing market during the forecast period?

North America is expected to account for the largest market share from 2026 to 2036.

Who are the prominent players in the global genomic surveillance/sequencing market?

Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies plc, BGI Genomics Co., Ltd., QIAGEN N.V., Agilent Technologies, Inc., Revvity, Inc., Danaher Corporation, bioMérieux SA, Bio-Rad Laboratories, Inc., Eurofins Scientific SE, Twist Bioscience Corporation, Guardant Health, Inc., Myriad Genetics, Inc., Natera, Inc., 10x Genomics, Inc., Element Biosciences, Inc., and Singular Genomics Systems, Inc. among othe

  1. Preface
    • Market Definition and Scope
    • Market Segmentation
    • Key Research Objectives
    • Research Highlights
  2. Assumptions and Research Methodology
  3. Executive Summary: Global Genomic Surveillance/Sequencing Market
  4. Market Overview
    • Introduction
      • Segment Definition
      • Industry Evolution / Developments
    • Overview
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Global Genomic Surveillance/Sequencing Market Analysis and Forecast, 2021-2036
      • Market Revenue Projections (USD Billion)
  5. Key Insights
    • Market Trends
    • Healthcare Expenditure by Country/Region
    • Cost-per-Genome Trend Analysis
    • Recent Technological Advancements
    • Technology Advancement Analysis
    • Product Pipeline Analysis
    • Patent Analysis
    • Emerging Therapy Trends
    • Pricing Analysis
    • Reimbursement Scenario
    • Regulatory Landscape
    • PESTLE Analysis
    • PORTER's Five Forces Analysis
    • Value Chain Analysis
    • Company Profiles
    • Unmet Needs Analysis
    • End-User Preference Analysis
    • Investment & Funding Landscape
  6. Global Genomic Surveillance/Sequencing Market Analysis and Forecast, by Product/Therapy Type
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Attractiveness Analysis, by Product/Therapy Type
  7. Global Genomic Surveillance/Sequencing Market Analysis and Forecast, by Product & Service
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Attractiveness Analysis, by Product & Service
  8. Global Genomic Surveillance/Sequencing Market Analysis and Forecast, by Technology
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Attractiveness Analysis, by Technology
  9. Global Genomic Surveillance/Sequencing Market Analysis and Forecast, by Workflow
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Attractiveness Analysis, by Workflow
  10. Global Genomic Surveillance/Sequencing Market Analysis and Forecast, by Application
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Attractiveness Analysis, by Application
  11. Global Genomic Surveillance/Sequencing Market Analysis and Forecast, by End-user
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis, by End-user
  12. Global Genomic Surveillance/Sequencing Market Analysis and Forecast, by Region
    • Key Findings
    • Market Value Forecast, by Region, 2021-2036
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
    • Market Attractiveness Analysis, by Region
  13. North America Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • U.S.
      • Canada
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
      • By Country/Sub-region
  14. U.S. Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  15. Canada Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  16. Europe Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • The Netherlands
      • Switzerland
      • Rest of Europe
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
      • By Country/Sub-region
  17. Germany Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  18. United Kingdom Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  19. France Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  20. Italy Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  21. Spain Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  22. The Netherlands Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  23. Switzerland Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  24. Rest of Europe Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  25. Asia Pacific Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • China
      • India
      • Japan
      • South Korea
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
      • By Country/Sub-region
  26. China Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  27. India Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  28. Japan Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  29. South Korea Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  30. Australia & New Zealand Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  31. Rest of Asia Pacific Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  32. Latin America Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
      • By Country/Sub-region
  33. Brazil Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  34. Mexico Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  35. Argentina Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  36. Rest of Latin America Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  37. Middle East & Africa Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
      • By Country/Sub-region
  38. GCC Countries Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  39. South Africa Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  40. Rest of Middle East & Africa Genomic Surveillance/Sequencing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product/Therapy Type, 2021-2036
      • Monoclonal Antibodies
      • Checkpoint Inhibitors
      • CAR-T Cell Therapy
      • Cancer Vaccines
      • Bispecific Antibodies
      • Antibody-Drug Conjugates (ADCs)
      • Cytokines & Immune Modulators
      • Oncolytic Virus Therapy
    • Market Value Forecast, by Product & Service, 2021-2036
      • Instruments/Systems
      • Consumables & Reagents
      • Software & Data Analytics
      • Services
    • Market Value Forecast, by Technology, 2021-2036
      • Next-Generation Sequencing (NGS)
      • Sanger Sequencing
      • PCR-based Sequencing/Detection
      • Microarray Technology
      • Nanopore Sequencing
      • Others
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing (Sample Prep, Library Prep)
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Infectious Disease Surveillance (Pathogen/Outbreak Monitoring)
      • Oncology
      • Genetic & Rare Disease Testing
      • Reproductive Health (NIPT, Carrier Screening)
      • Agricultural & Environmental Genomics
      • Forensic Genomics
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Diagnostic Laboratories
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Government & Public Health Agencies
      • Contract Research Organizations (CROs)
    • Market Attractiveness Analysis
      • By Product/Therapy Type
      • By Product & Service
      • By Technology
      • By Workflow
      • By Application
      • By End-user
  41. Competition Landscape
    • Market Player - Competition Matrix (By Tier and Size of Companies)
    • Market Share Analysis, by Company (2025)
    • Company Profiles
      • Illumina, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Thermo Fisher Scientific Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • F. Hoffmann-La Roche Ltd.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Pacific Biosciences of California, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Oxford Nanopore Technologies plc
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • BGI Genomics Co., Ltd.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • QIAGEN N.V.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Agilent Technologies, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Revvity, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Danaher Corporation
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • bioMérieux SA
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Eurofins Scientific SE
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Twist Bioscience Corporation
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Guardant Health, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Myriad Genetics, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Natera, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • 10x Genomics, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Element Biosciences, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Singular Genomics Systems, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments

List of Tables

Table 01: Global Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 02: Global Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 03: Global Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 04: Global Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 05: Global Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 06: Global Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 07: North America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 08: North America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 09: North America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 10: North America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 11: North America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 12: North America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 13: U.S. Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 14: U.S. Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 15: U.S. Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 16: U.S. Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 17: U.S. Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 18: Canada Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 19: Canada Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 20: Canada Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 21: Canada Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 22: Canada Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 23: Europe Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 24: Europe Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 25: Europe Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 26: Europe Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 27: Europe Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 28: Europe Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 29: Germany Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 30: Germany Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 31: Germany Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 32: Germany Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 33: Germany Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 34: U.K. Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 35: U.K. Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 36: U.K. Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 37: U.K. Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 38: U.K. Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 39: France Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 40: France Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 41: France Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 42: France Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 43: France Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 44: Italy Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 45: Italy Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 46: Italy Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 47: Italy Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 48: Italy Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 49: Spain Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 50: Spain Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 51: Spain Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 52: Spain Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 53: Spain Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 54: The Netherlands Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 55: The Netherlands Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 56: The Netherlands Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 57: The Netherlands Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 58: The Netherlands Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 59: Switzerland Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 60: Switzerland Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 61: Switzerland Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 62: Switzerland Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 63: Switzerland Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 64: Rest of Europe Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 65: Rest of Europe Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 66: Rest of Europe Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 67: Rest of Europe Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 68: Rest of Europe Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 69: Asia Pacific Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 70: Asia Pacific Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 71: Asia Pacific Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 72: Asia Pacific Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 73: Asia Pacific Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 74: Asia Pacific Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 75: China Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 76: China Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 77: China Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 78: China Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 79: China Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 80: Japan Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 81: Japan Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 82: Japan Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 83: Japan Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 84: Japan Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 85: India Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 86: India Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 87: India Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 88: India Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 89: India Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 90: South Korea Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 91: South Korea Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 92: South Korea Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 93: South Korea Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 94: South Korea Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 95: Australia and New Zealand Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 96: Australia and New Zealand Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 97: Australia and New Zealand Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 98: Australia and New Zealand Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 99: Australia and New Zealand Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 100: Rest of Asia Pacific Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 101: Rest of Asia Pacific Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 102: Rest of Asia Pacific Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 103: Rest of Asia Pacific Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 104: Rest of Asia Pacific Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 105: Latin America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 106: Latin America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 107: Latin America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 108: Latin America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 109: Latin America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 110: Latin America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 111: Brazil Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 112: Brazil Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 113: Brazil Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 114: Brazil Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 115: Brazil Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 116: Mexico Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 117: Mexico Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 118: Mexico Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 119: Mexico Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 120: Mexico Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 121: Argentina Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 122: Argentina Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 123: Argentina Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 124: Argentina Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 125: Argentina Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 126: Rest of Latin America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 127: Rest of Latin America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 128: Rest of Latin America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 129: Rest of Latin America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 130: Rest of Latin America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 131: Middle East and Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 132: Middle East and Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 133: Middle East and Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 134: Middle East and Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 135: Middle East and Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 136: Middle East and Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 137: GCC Countries Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 138: GCC Countries Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 139: GCC Countries Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 140: GCC Countries Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 141: GCC Countries Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 142: South Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 143: South Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 144: South Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 145: South Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 146: South Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 147: Rest of Middle East and Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 148: Rest of Middle East and Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 149: Rest of Middle East and Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 150: Rest of Middle East and Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 151: Rest of Middle East and Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036

List of Figures

Figure 01: Global Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 02: Global Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 03: Global Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 04: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Instruments/Systems, 2021 to 2036
Figure 05: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Consumables & Reagents, 2021 to 2036
Figure 06: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Software & Data Analytics, 2021 to 2036
Figure 07: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Services, 2021 to 2036
Figure 08: Global Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 09: Global Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 10: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Next-Generation Sequencing (NGS), 2021 to 2036
Figure 11: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Sanger Sequencing, 2021 to 2036
Figure 12: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by PCR-based Sequencing/Detection, 2021 to 2036
Figure 13: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Microarray Technology, 2021 to 2036
Figure 14: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Nanopore Sequencing, 2021 to 2036
Figure 15: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Others, 2021 to 2036
Figure 16: Global Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 17: Global Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 18: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Pre-Sequencing (Sample Prep, Library Prep), 2021 to 2036
Figure 19: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Sequencing, 2021 to 2036
Figure 20: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Data Analysis, 2021 to 2036
Figure 21: Global Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 22: Global Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 23: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Infectious Disease Surveillance (Pathogen/Outbreak Monitoring), 2021 to 2036
Figure 24: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Oncology, 2021 to 2036
Figure 25: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Genetic & Rare Disease Testing, 2021 to 2036
Figure 26: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Reproductive Health (NIPT, Carrier Screening), 2021 to 2036
Figure 27: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Agricultural & Environmental Genomics, 2021 to 2036
Figure 28: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Forensic Genomics, 2021 to 2036
Figure 29: Global Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 30: Global Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 31: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Hospitals & Diagnostic Laboratories, 2021 to 2036
Figure 32: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Academic & Research Institutes, 2021 to 2036
Figure 33: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Pharmaceutical & Biotechnology Companies, 2021 to 2036
Figure 34: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Government & Public Health Agencies, 2021 to 2036
Figure 35: Global Genomic Surveillance/Sequencing Market Revenue (USD Billion), by Contract Research Organizations (CROs), 2021 to 2036
Figure 36: Global Genomic Surveillance/Sequencing Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 37: Global Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 38: North America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 39: North America Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 40: North America Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 41: North America Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 42: North America Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 43: North America Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 44: North America Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 45: North America Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 46: North America Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 47: North America Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 48: North America Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 49: North America Genomic Surveillance/Sequencing Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 50: North America Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 51: U.S. Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 52: U.S. Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 53: U.S. Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 54: U.S. Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 55: U.S. Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 56: U.S. Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 57: U.S. Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 58: U.S. Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 59: U.S. Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 60: U.S. Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 61: U.S. Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 62: Canada Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 63: Canada Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 64: Canada Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 65: Canada Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 66: Canada Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 67: Canada Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 68: Canada Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 69: Canada Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 70: Canada Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 71: Canada Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 72: Canada Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 73: Europe Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 74: Europe Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 75: Europe Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 76: Europe Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 77: Europe Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 78: Europe Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 79: Europe Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 80: Europe Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 81: Europe Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 82: Europe Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 83: Europe Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 84: Europe Genomic Surveillance/Sequencing Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 85: Europe Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 86: Germany Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 87: Germany Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 88: Germany Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 89: Germany Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 90: Germany Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 91: Germany Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 92: Germany Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 93: Germany Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 94: Germany Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 95: Germany Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 96: Germany Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 97: U.K. Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 98: U.K. Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 99: U.K. Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 100: U.K. Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 101: U.K. Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 102: U.K. Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 103: U.K. Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 104: U.K. Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 105: U.K. Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 106: U.K. Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 107: U.K. Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 108: France Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 109: France Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 110: France Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 111: France Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 112: France Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 113: France Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 114: France Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 115: France Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 116: France Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 117: France Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 118: France Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 119: Italy Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 120: Italy Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 121: Italy Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 122: Italy Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 123: Italy Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 124: Italy Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 125: Italy Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 126: Italy Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 127: Italy Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 128: Italy Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 129: Italy Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 130: Spain Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 131: Spain Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 132: Spain Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 133: Spain Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 134: Spain Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 135: Spain Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 136: Spain Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 137: Spain Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 138: Spain Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 139: Spain Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 140: Spain Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 141: The Netherlands Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 142: The Netherlands Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 143: The Netherlands Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 144: The Netherlands Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 145: The Netherlands Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 146: The Netherlands Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 147: The Netherlands Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 148: The Netherlands Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 149: The Netherlands Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 150: The Netherlands Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 151: The Netherlands Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 152: Switzerland Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 153: Switzerland Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 154: Switzerland Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 155: Switzerland Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 156: Switzerland Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 157: Switzerland Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 158: Switzerland Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 159: Switzerland Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 160: Switzerland Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 161: Switzerland Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 162: Switzerland Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 163: Rest of Europe Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 164: Rest of Europe Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 165: Rest of Europe Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 166: Rest of Europe Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 167: Rest of Europe Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 168: Rest of Europe Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 169: Rest of Europe Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 170: Rest of Europe Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 171: Rest of Europe Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 172: Rest of Europe Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 173: Rest of Europe Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 174: Asia Pacific Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 175: Asia Pacific Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 176: Asia Pacific Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 177: Asia Pacific Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 178: Asia Pacific Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 179: Asia Pacific Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 180: Asia Pacific Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 181: Asia Pacific Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 182: Asia Pacific Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 183: Asia Pacific Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 184: Asia Pacific Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 185: Asia Pacific Genomic Surveillance/Sequencing Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 186: Asia Pacific Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 187: China Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 188: China Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 189: China Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 190: China Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 191: China Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 192: China Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 193: China Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 194: China Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 195: China Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 196: China Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 197: China Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 198: Japan Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 199: Japan Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 200: Japan Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 201: Japan Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 202: Japan Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 203: Japan Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 204: Japan Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 205: Japan Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 206: Japan Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 207: Japan Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 208: Japan Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 209: India Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 210: India Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 211: India Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 212: India Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 213: India Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 214: India Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 215: India Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 216: India Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 217: India Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 218: India Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 219: India Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 220: South Korea Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 221: South Korea Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 222: South Korea Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 223: South Korea Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 224: South Korea Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 225: South Korea Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 226: South Korea Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 227: South Korea Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 228: South Korea Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 229: South Korea Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 230: South Korea Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 231: Australia and New Zealand Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 232: Australia and New Zealand Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 233: Australia and New Zealand Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 234: Australia and New Zealand Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 235: Australia and New Zealand Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 236: Australia and New Zealand Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 237: Australia and New Zealand Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 238: Australia and New Zealand Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 239: Australia and New Zealand Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 240: Australia and New Zealand Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 241: Australia and New Zealand Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 242: Rest of Asia Pacific Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 243: Rest of Asia Pacific Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 244: Rest of Asia Pacific Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 245: Rest of Asia Pacific Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 246: Rest of Asia Pacific Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 247: Rest of Asia Pacific Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 248: Rest of Asia Pacific Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 249: Rest of Asia Pacific Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 250: Rest of Asia Pacific Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 251: Rest of Asia Pacific Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 252: Rest of Asia Pacific Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 253: Latin America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 254: Latin America Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 255: Latin America Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 256: Latin America Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 257: Latin America Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 258: Latin America Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 259: Latin America Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 260: Latin America Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 261: Latin America Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 262: Latin America Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 263: Latin America Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 264: Latin America Genomic Surveillance/Sequencing Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 265: Latin America Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 266: Brazil Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 267: Brazil Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 268: Brazil Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 269: Brazil Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 270: Brazil Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 271: Brazil Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 272: Brazil Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 273: Brazil Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 274: Brazil Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 275: Brazil Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 276: Brazil Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 277: Mexico Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 278: Mexico Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 279: Mexico Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 280: Mexico Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 281: Mexico Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 282: Mexico Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 283: Mexico Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 284: Mexico Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 285: Mexico Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 286: Mexico Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 287: Mexico Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 288: Argentina Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 289: Argentina Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 290: Argentina Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 291: Argentina Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 292: Argentina Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 293: Argentina Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 294: Argentina Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 295: Argentina Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 296: Argentina Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 297: Argentina Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 298: Argentina Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 299: Rest of Latin America Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 300: Rest of Latin America Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 301: Rest of Latin America Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 302: Rest of Latin America Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 303: Rest of Latin America Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 304: Rest of Latin America Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 305: Rest of Latin America Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 306: Rest of Latin America Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 307: Rest of Latin America Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 308: Rest of Latin America Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 309: Rest of Latin America Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 310: Middle East and Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 311: Middle East and Africa Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 312: Middle East and Africa Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 313: Middle East and Africa Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 314: Middle East and Africa Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 315: Middle East and Africa Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 316: Middle East and Africa Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 317: Middle East and Africa Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 318: Middle East and Africa Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 319: Middle East and Africa Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 320: Middle East and Africa Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 321: Middle East and Africa Genomic Surveillance/Sequencing Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 322: Middle East and Africa Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 323: GCC Countries Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 324: GCC Countries Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 325: GCC Countries Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 326: GCC Countries Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 327: GCC Countries Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 328: GCC Countries Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 329: GCC Countries Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 330: GCC Countries Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 331: GCC Countries Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 332: GCC Countries Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 333: GCC Countries Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 334: South Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 335: South Africa Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 336: South Africa Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 337: South Africa Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 338: South Africa Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 339: South Africa Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 340: South Africa Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 341: South Africa Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 342: South Africa Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 343: South Africa Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 344: South Africa Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 345: Rest of Middle East and Africa Genomic Surveillance/Sequencing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 346: Rest of Middle East and Africa Genomic Surveillance/Sequencing Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 347: Rest of Middle East and Africa Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 348: Rest of Middle East and Africa Genomic Surveillance/Sequencing Market Value Share Analysis, by Technology, 2025 and 2036
Figure 349: Rest of Middle East and Africa Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 350: Rest of Middle East and Africa Genomic Surveillance/Sequencing Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 351: Rest of Middle East and Africa Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 352: Rest of Middle East and Africa Genomic Surveillance/Sequencing Market Value Share Analysis, by Application, 2025 and 2036
Figure 353: Rest of Middle East and Africa Genomic Surveillance/Sequencing Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 354: Rest of Middle East and Africa Genomic Surveillance/Sequencing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 355: Rest of Middle East and Africa Genomic Surveillance/Sequencing Market Attractiveness Analysis, by End-user, 2026 to 2036

Copyright © Transparency Market Research, Inc. All Rights reserved

Genomic Surveillance/Sequencing Market

Buy This ReportBuy Now